Taipei Medical University Institutional Repository:Item 987654321/59320
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45069/58245 (77%)
造訪人次 : 2372029      線上人數 : 179
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/59320


    題名: 阿托伐他汀作用於慶大黴素誘導大鼠腎毒性之差異性蛋白質體分析
    Differential proteomic analysis of the effect of atorvastatin on gentamicin-induced nephrotoxicity in rats
    作者: 李梅君
    Lee, Mei-Chun
    貢獻者: 李仁愛
    關鍵詞: 阿托伐他汀 (atorvastatin);慶大黴素 (gentamicin);腎毒性;蛋白質體
    atorvastatin;gentamicin;nephrotoxicity;proteomic
    日期: 2015-06-17
    上傳時間: 2020-08-11 15:46:09 (UTC+8)
    摘要: 降血脂藥物阿托伐他汀 (atorvastatin, ATO)是3-hydroxy-3-methyl-3-glutarylcoenzyme A (HMG-CoA) reductase的抑制劑,它同時可以抑制non-steroidal isoprenoid compounds的合成,故具有多效性。研究發現ATO具有防止慶大黴素 (gentamicin, GM)引起的腎毒性,但詳細機轉仍不明,且GM引起腎細胞毒性的詳細機轉仍有待進一步闡明。因此,本研究藉由蛋白質體分析方法研究ATO對於GM引起腎毒性大鼠的療效影響與作用機轉。
    蛋白質體分析方法主要是將大鼠的腎臟組織均質化並利用螢光衍生化試劑DAABD-Cl後,經螢光高效能液相層析儀分離並收集表現量具有統計差異的波峰,再進入液相層析串聯質譜儀與MASCOT資料庫進行蛋白質的鑑定,再使用生物醫學分析研發軟體暨資料庫Ingenuity Pathways Analysis,建構蛋白質的毒性與功能與蛋白質之間的相關性路徑與機轉。
    蛋白質體分析結果,共有49個具有表現差異的蛋白質,GM腎毒性與粒線體功能失調、脂肪酸代謝與氧化壓力及其上游調控蛋白PPARα具高度相關性。與GM腎毒性最具相關的蛋白質有sodium-hydrogen exchanger regulatory factor (SLC9A3R1)、cathepsin V (CTSV)與transthyretin,蛋白質表現量在SLC9A3R1與transthyretin是下調,CTSV是上調。ATO介入治療下,蛋白表現量皆有呈現回復的趨勢,特別是CTSV與SLC9A3R1 ( p<0.05)。由於CTSV與SLC9A3R1分別為溶酶體磷脂質代謝與細胞膜運輸的相關蛋白質,因此推測ATO可能是因為藉由改善磷脂質的代謝而降低phospholipidosis,以及增強調控細胞酸鹼值與容積的平衡來改善GM引起的腎毒性。另外,transthyretin與cathepsin V可能是GM引起腎毒性專一的biomarkers。
    Atorvastatin (ATO) belonged to 3-hydroxy-3-methyl-3-glutaryl coenzyme A (HMG-CoA) reductase inhibitor. It also inhibited the synthesis of non-steroidal isoprenoid compounds and possessed pleotric effect. ATO role in preventing gentamicin (GM)-induced renal injury was well-established. However, the detailed mechanism remained obscure. Althought underlying multifaceted mechanisms involving in GM-induced nephrotoxicity were well known, further work on elucidating the major mechanism was needed. By using proteomic approach, we conducted mass spectrometry analysis to investigate the effects and mechanisms of ATO treatment in GM-induceed nephrotoxicity rats.
    The homogenate of kidney of rats were reacted with DAABD-Cl. The derivatized proteins were separated and quantified by high performance liquid chromatography with fluorescence detection (FD-HPLC). The significantly differential proteins were identified by liquid chromatography tandem mass spectrometry (LC-MS/MS) using a MASCOT database searching system. Finally, we used Ingenuity Pathway Analysis to find the relationships, mechanisms, functions, pathways of relevance, and protein networks.
    According to the experimental results, 49 proteins were significantly differential and identified. The most significant mechanisms of nephrotoxicity caused by GM were mitochondrial dysfunction, fatty acid metabolism and oxidative stress. Their upstream regulator was also found to be PPARα. The proteins involving in GM nephrotoxicity were sodium-hydrogen exchanger regulatory factor (SLC9A3R1), cathepsin V (CTSV) and transthyretin. The expression of CTSV was up-regulated and SLC9A3R1 and transthyretin were down-regulated in GM group. After ATO intervention, we observed a reverse enrichment pattern of the expression of them, especially in CTSV and SLC9A3R1 (p<0.05). CTSV and SLC9A3R1were associated with lysosomal phospholipid metabolism and cell membrane transporters separately. Therefore, we predicted ATO may improve abnormal phospholipid metabolism and phospholipidosis caused by GM. ATO may also alleviate cell volume homeostasis and reverse the interference of GM to the transporter. Proteomic results also provided clues for GM-induced nephrotoxicity biomarkers such as CTSV and transthyretin.
    描述: 碩士
    指導教授:李仁愛
    委員:田履黛
    委員:陳世銘
    資料類型: thesis
    顯示於類別:[臨床藥物基因體學暨蛋白質體學碩士學位學程] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML177檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋